Effective treatments for urticarial vasculitis

October 31, 2018, Charité - Universitätsmedizin Berlin
Credit: CC0 Public Domain

What treatments are available for patients with the rare inflammatory disease known as urticarial vasculitis? How effective are these treatments? Researchers from Charité - Universitätsmedizin Berlin embarked on a systematic review and meta-analysis to address these questions. Recently published in the Journal of Allergy and Clinical Immunology, the results of this meta-analysis reveal which of the available treatment options offer more promising outcomes.

Urticarial vasculitis is a rare inflammatory disease of blood vessels that affects between 20,000 and 50,000 people in Germany every year. The disease remains difficult to treat, and none of the drugs currently used in the treatment of urticarial vasculitis have been specifically approved for this purpose. Physicians use an array of treatment options to help patients, and do so with widely varying results. With this in mind, a team of researchers led by Prof. Dr. Marcus Maurer, Head of Research at Charité's Department of Dermatology, Venereology and Allergology, set out to determine which of the options available would prove effective in treating urticarial vasculitis. To do so, the researchers carried out a meta-analysis of 250 publications, all of which reported on the treatment of patients with urticarial vasculitis. The central result of their meta-analysis is that patients with urticarial vasculitis appear to benefit from treatment with corticosteroids, biologics and immunosuppressive agents. In contrast, antihistamines and other anti-inflammatory drugs appeared to be ineffective.

Antihistamines are commonly used to treat patients with urticaria. While urticaria and urticarial vasculitis share a similar symptom complex (itching, wheals, redness and swelling of the skin), they do not represent variants of the same condition. The similarities of their dermatological manifestations mean that urticarial vasculitis is often mistaken for ordinary urticaria.

"Our research is helping to ensure that we can improve the treatment of patients with urticarial vasculitis," says Prof. Maurer. He adds: "Our future research projects will aim to develop criteria for improving the diagnosis of urticarial vasculitis. We are also hoping to develop methods that will enable us to objectively measure a patient's response to . These efforts will form the basis of future research to develop treatments specifically targeted at urticarial vasculitis."

Explore further: Allergy drug may be effective in kidney disease

More information: Pavel Kolkhir et al, Treatment of urticarial vasculitis: A systematic review, Journal of Allergy and Clinical Immunology (2018). DOI: 10.1016/j.jaci.2018.09.007

Related Stories

Allergy drug may be effective in kidney disease

October 20, 2015
A current treatment for asthma may benefit patients with kidney disease, according to latest research at Monash University.

Glove-related hand urticaria may be rising in health care workers

December 6, 2015
(HealthDay)—Health care workers are at high risk of glove-related hand urticaria, an occupational issue that may be increasing, according to a research letter published online Nov. 27 in the British Journal of Dermatology.

Interferon-free, tailored Tx beneficial in HCV-associated MC

August 16, 2016
(HealthDay)—Interferon-free direct-acting antiviral (DAA) therapy is beneficial for hepatitis C virus (HCV)-associated mixed cryoglobulinemia (MC) vasculitis, according to a study published online Aug. 2 in Hepatology.

Predicting relapses in patients with autoimmune vascular disease

May 23, 2018
Patients with an autoimmune disorder called antineutrophil cytoplasmic antibody-associated vasculitis produce antibodies that damage blood vessels in the body. In some cases, patients' antibodies target a protein called myeloperoxidase. ...

New treatment approach for autoimmune disorder

November 3, 2017
Researchers from Charité—Universitätsmedizin Berlin have been able to improve their understanding of the key mechanism involved in the pathogenesis of a serious autoimmune disease. For the first time, researchers were ...

Trials examine immune drug's potential to treat different forms of vasculitis

January 30, 2017
Two new studies provide valuable insights into the treatment of different types of vasculitis, which are conditions that cause blood vessels to become inflamed. In the studies, which appear in Arthritis & Rheumatology, investigators ...

Recommended for you

Patchy distribution of joint inflammation resolved

November 16, 2018
Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic, disabling diseases with a poor outcome for loco-motoric function if left untreated. RA and SpA each affect ...

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

Inflammation can lead to circadian sleep disorders

October 31, 2018
Inflammation, which is the root cause of autoimmune disorders including arthritis, Type 1 diabetes, irritable bowel syndrome and Crohn's disease, has unexpected effects on body clock function and can lead to sleep and shiftwork-type ...

Machine learning tool predicts the potential of peptides as immune activators

October 23, 2018
The immune system keeps T cells under control by regulating precisely when they can respond to a pathogen. For instance, helper T cells only turn "on" if other immune cells, such as antigen-presenting cells (APCs) present ...

A new mechanism in the control of inflammation

October 18, 2018
After infection or tissue injury, the inflammatory immune response attacks the infection and repairs the damaged tissue. However, sometimes excess inflammation can have the opposite effect, increasing injury in a process ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.